Cizzle Biotechnology Holdings Plc chart

Last update: 2022-12-30
Key statistics and financials
Revenue per share N/A
Dividend & YieldN/A£ (N/A)
Beta N/A
Market capitalization 5.95M
Operating cash flow -852k
ESG Scores unknown

Company description

Cizzle Biotechnology Holdings Plc engages in development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.

Sector: Healthcare - Industry: Biotechnology

Financial data

Financial Statements

Cashflow Statement 2017-12-31 2018-12-31 2020-12-31 2021-12-31
Change To Liabilities -2k -204k
Total Cashflows From Investing Activities -154k -154k -154k -154k
Net Borrowings 10k 10k 10k -10k
Total Cash From Financing Activities 10k 10k 10k 2.03M
Change To Operating Activities
Issuance Of Stock 2.04M 2.04M 2.04M 2.04M
Net Income -126.36k -27.89k -14k -3.92M
Change In Cash -6k -6k -6k 868k
Effect Of Exchange Rate
Total Cash From Operating Activities -16k -16k -16k -1.01M
Depreciation
Change To Account Receivables 7k 7k 7k 7k
Other Cashflows From Financing Activities
Change To Netincome 3.08M 3.08M 3.08M 3.08M
Capital Expenditures

Income Statement 2017-12-31 2018-12-31 2020-12-31 2021-12-31
Research Development 161k 161k 161k 161k
Income Before Tax -148.04k -27.89k -14k -3.96M
Net Income -126.36k -27.89k -14k -3.92M
Selling General Administrative 76.44k 53.82k 14k 637k
Gross Profit -73.83k 25k
Ebit -148.04k -27.89k -14k -798k
Operating Income -148.04k -27.89k -14k -798k
Interest Expense
Income Tax Expense -21.68k 1 -37k
Total Revenue 25k
Cost Of Revenue 73.83k
Total Other Income ExpenseNet 9 7 -3.16M
Net Income From Continuing Ops -126.36k -27.89k -14k -3.92M
Net Income Applicable To Common Shares -126.36k -27.89k -14k -3.92M

Balance Sheet Statement 2017-12-31 2018-12-31 2020-12-31 2021-12-31
Total Liabilities 11.89k 20.71k 18k 218k
Total Stockholder Equity 31.23k 3.34k -8k 937k
Other Current Liabilities 929
Total Assets 43.11k 24.05k 10k 1.16M
Common Stock 3.14k 3.14k 3k 3.49M
Other Current Assets
Retained Earnings -1.56M -1.59M -1.6M -5.52M
Treasury Stock -29.61M
Cash 13.32k 19.89k 7k 875k
Total Current Liabilities 11.89k 20.71k 18k 218k
Other Stockholder Equity -29.61M
Property, Plant, and Equipment 1.45k
Total Current Assets 41.66k 24.05k 10k 955k
Net Tangible Assets 31.23k 3.34k -8k 737k
Net Receivables 27.29k 2.88k 51k
Accounts Payable 7.21k 13.64k 2k 111k


Insider Transactions

Here are the insider transactions of stock shares related to Cizzle Biotechnology Holdings Plc:

Filer Name Transaction Text Ownership Date Filer Relation Shares
Coverley (Dawn Alison)Exercise of Option at price 0.02 per share.D2022-09-283.69M
Miller (Alan)D2022-09-26
Lee (Nigel Ronald)D2022-09-26
Coverley (Dawn Alison)D2022-09-26
Yorkshire Cancer ResearchD2022-05-31
University of YorkD2022-05-31
University of SheffieldD2022-05-31
University of LeedsD2022-05-31
Coverley (Dawn Alison)D2022-05-31
Conduit Pharmaceuticals LtdD2022-02-2825M
Conduit Pharmaceuticals LtdD2022-02-16
Finance Yorkshire Seedcorn LPD2022-02-0416M
Nirland LtdD2022-01-3112.6M
Rose Noble LtdD2021-12-0615.2M
Nirland LtdD2021-12-06
Finance Yorkshire Seedcorn LPD2021-11-251M
Finance Yorkshire Seedcorn LPD2021-05-14
University of LeedsD2021-05-14
Rose Noble LtdD2021-05-14
University of SheffieldD2021-05-14
University of YorkD2021-05-14
Coverley (Dawn Alison)D2021-05-14
Lee (Nigel Ronald)D2021-05-14
Glogowski (Antos)D2021-05-14
Yorkshire Cancer ResearchD2021-05-14

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to Cizzle Biotechnology Holdings Plc. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on Cizzle Biotechnology Holdings Plc

Here is the result of two systematic investment strategies applied to Cizzle Biotechnology Holdings Plc. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on Cizzle Biotechnology Holdings Plc

The following chart shows the equity curve of the two systematic investment strategies applied to Cizzle Biotechnology Holdings Plc:

Cizzle Biotechnology Holdings Plc automated entries

The systematic investment strategy that buys the first day of the month would give a performance of -3.64% on the backtest period.

Performance at glance

Performance

-3.64 %

Latent gain

-9.12 £

Invested capital

250.8 £

Annualized return

-10.71 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on Cizzle Biotechnology Holdings Plc

This is the result of two momentum investment strategies applied to Cizzle Biotechnology Holdings Plc. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on Cizzle Biotechnology Holdings Plc

The following chart shows all the entries opened by the momentum investment system on Cizzle Biotechnology Holdings Plc:

Cizzle Biotechnology Holdings Plc momentum entries
  • The first momentum investment strategy would give -1.4% of return on Cizzle Biotechnology Holdings Plc. That represents -3.48£ of latent gain with 249.4£ of employed capital.
  • The second momentum investment strategy would give 0% of return on Cizzle Biotechnology Holdings Plc. That represents 0.0£ of latent gain with 0.0£ of employed capital.
Performance at glance (1Q Momentum)

Performance

-1.4 %

Latent gain

-3.48 £

Invested capital

249.4 £

Annualized return

-0.0 %
Performance at glance (2Q Momentum)

Performance

0 %

Latent gain

0.0 £

Invested capital

0.0 £

Annualized return

-0.0 %

Momentum equity curve on Cizzle Biotechnology Holdings Plc

The following chart shows the equity curve of the two momentum strategies applied to Cizzle Biotechnology Holdings Plc:

Cizzle Biotechnology Holdings Plc momentum equity

Note: the dividends potentially given by Cizzle Biotechnology Holdings Plc are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Cizzle Biotechnology Holdings Plc

The following chart shows the employed capital evolution of the two momentum strategies on Cizzle Biotechnology Holdings Plc since the beginning:

Cizzle Biotechnology Holdings Plc

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250£, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000£.


Buy the dip strategy result on Cizzle Biotechnology Holdings Plc

Buy the dip entry openings on Cizzle Biotechnology Holdings Plc

Cizzle Biotechnology Holdings Plc

The performance achieved by the robo-advisor on Cizzle Biotechnology Holdings Plc is 0%. That represents 0.0$ of latent gain with 0.0£ of employed capital. The following chart shows Cizzle Biotechnology Holdings Plc stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of Cizzle Biotechnology Holdings Plc, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

0 %

Latent gain

0.0 £

Invested capital

0.0 £

Annualized return

-0.0 %

Equity curve of the strategy applied to Cizzle Biotechnology Holdings Plc

The following chart shows the result of the investment strategy applied to Cizzle Biotechnology Holdings Plc:

Cizzle Biotechnology Holdings Plc

Note: the dividends potentially given by Cizzle Biotechnology Holdings Plc are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Cizzle Biotechnology Holdings Plc

The following chart shows the employed capital evolution since the beginning of the investment strategy on Cizzle Biotechnology Holdings Plc:

Cizzle Biotechnology Holdings Plc

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on Cizzle Biotechnology Holdings Plc

In this section, I will compare the three previous investment strategies applied to Cizzle Biotechnology Holdings Plc.

Equity curve comparison on Cizzle Biotechnology Holdings Plc

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

Cizzle Biotechnology Holdings Plc investment strategy comparison

Employed capital comparison on Cizzle Biotechnology Holdings Plc

Cizzle Biotechnology Holdings Plc investment comparison

Performance comparison on Cizzle Biotechnology Holdings Plc

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment -3.64% -9.12£ 250.8£ -10.71%
Momentum 1 quarter -1.4% -3.48£ 249.4£ -14.0%
Momentum 2 quarters 0% 0.0£ 0.0£ -0.0%
Non-directional 0% 0.0£ 0.0£ -0.0%
Annualized return comparison

Automatic investment

-10.71 %

Momentum 1Q

-0.0 %

Momentum 2Q

-0.0 %

Non-directional

-0.0 %

Correlated stocks

Here are the most positively and negatively correlated stocks with Cizzle Biotechnology Holdings Plc:

Positive correlations

Most correlated stocks this year


Most correlated stocks last 3 months

Negative correlation

Most negatively correlated stocks this year


Most negatively correlated stocks last 3 months

Note: The algorithm computes the probability of correlation between Cizzle Biotechnology Holdings Plc and the other stocks. There may be false positives or some missing correlated stocks. If the price of Cizzle Biotechnology Holdings Plc does not vary for 36 weeks, the correlation calculation result will be wrong.


Company information

Company name Cizzle Biotechnology Holdings Plc
Country United Kingdom
City London
Address 60 Gracechurch Street
Phone
Website www.cizzlebiotechnology.com
FullTime employees 4
Industry Biotechnology
Sector Healthcare
Exchange XLON
Ticker CIZ.XLON
Market www.londonstockexchange.com

Cizzle Biotechnology Holdings Plc ESG Scores

Environment scores

Environment ESG Factors Scores
Environment Score 0
Peer Environment Performance unknown
Environment Percentile unknown
Palm Oil unknown
Nuclear unknown
Fur Leather unknown
GMO unknown
Coal unknown
Pesticides unknown
Animal Testing unknown

Social scores

Social ESG Factors Scores
Social Score 0
Peer Social Performance unknown
Social Percentile unknown
Highest Controversy unknown
Peer Highest Controversy Performance unknown
Adult unknown
Gambling unknown
Alcoholic unknown
Tobacco unknown
Catholic unknown
Controversial Weapons unknown
Small Arms unknown
Military Contract unknown
Peer Count unknown

Related Controversy:


Governance scores

Governance ESG Factors Scores
Governance Score 0
Peer Governance Performance unknown
Governance Percentile unknown

ESG at glance
Total ESG Scores: unknown
Environment Score: 0
Social Score: 0
Governance Score: 0

ESG Performance: unknown

Peer Group: unknown

Peer Esg Score Performance: unknown

Rating Year: unknown

Rating Month: unknown

Max Age: unknown

Percentile: unknown